PPCB
Propanc Biopharma·NASDAQ
--
--(--)
--
--(--)
PPCB Filings
Filing Date
Form Description
Form Type
2026-02-02
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-02-02 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2026-01-30
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-30 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2026-01-12
Form EFFECT - Notice of Effectiveness
2026-01-12 ·
Form EFFECT - Notice of Effectiveness
2026-01-07
Form 8-K - Current report
Key Events
2026-01-07 · Key Events
Form 8-K - Current report
2025-12-30
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-12-30 ·
Form S-1 - General form for registration of securities under the Securities Act of 1933
2025-12-29
Form DEF 14C - Other definitive information statements
2025-12-29 ·
Form DEF 14C - Other definitive information statements
2025-12-10
Form PRE 14C - Other preliminary information statements
2025-12-10 ·
Form PRE 14C - Other preliminary information statements
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Financials
2025-11-14 · Financials
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025-11-10
Form 8-K - Current report
Key Events
2025-11-10 · Key Events
Form 8-K - Current report
